Omnicell, Inc.

OMCL Healthcare Health Information Services

Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024. In the quarter to June 2026, revenue grew 7.45%, EPS grew 341.7%, free cash flow grew 107.9% and total debt fell 50.8%, each against the same quarter a year earlier.

35.39 0.56 −1.56%
Market cap
$1.6B
P/E
41.6×
Fwd P/E
55.1×
Dividend yield
—
F-score
7/9
Altman Z
2.69
Beneish M
−2.85
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

70.81 1,132.50 75.86 48.85
P/S ratio
1.18 1.76 1.23 1.52
P/FCF ratio
14.79 30.02 15.47 14.94
P/Operating CF
49.06 68.60 27.76 27.72
P/B ratio
1.14 1.69 1.20 1.47
EV/Sales
1.32 1.88 1.32 1.56
EV/EBITDA
14.44 23.59 13.32 13.45
EV/FCF
16.52 32.12 16.52 15.34
Current Ratio
1.44 1.43 1.50 1.64
Net Debt/EBITDA
(0.42) (1.27) (1.88) (2.31)
Debt/Equity
0.14 0.14 0.13 0.13
Earnings Yield
1.41% 0.09% 1.32% 2.05%
Free Cash Flow Yield
6.76% 3.33% 6.47% 6.69%
Free Cash Flow per Share
0.31 0.40 0.85 1.22
Book value per Share
26.81 26.80 27.73 28.32
Free Cash Flow
13.99 18.36 38.63 55.78
EV/EBIT
90.35 431.81 48.06 33.55
Other line items

Show all line items

Columns are period end dates